Difference between revisions of "Perfusion, Diffusion and Flow-MRI Biomarker Ctte"
Jump to navigation
Jump to search
| (14 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
:Co-chairs: Michael Boss, PhD; John Kirsch, PhD; Daniel Barboriak, MD | :Co-chairs: Michael Boss, PhD; John Kirsch, PhD; Daniel Barboriak, MD | ||
| − | : | + | :RSNA Staff Support: Susan Stanfa |
* [http://tinyurl.com/QIBA-PDF-MRI-Roster Roster] | * [http://tinyurl.com/QIBA-PDF-MRI-Roster Roster] | ||
| − | + | '''NOTICE''': This committee has been [[Committee Sunset Process|dissolved]] as of June 6, 2018. | |
| − | *[[MR | + | * PDF served as the launching point for work on [[DWI MR Biomarker Ctte | DWI]], [[DCE MRI Biomarker Ctte |DCE]], and [[DSC MRI Biomarker Ctte | DSC]], which now have their own Biomarker Committees, as well as DTI. |
| − | + | * This page is persisted to provide access to earlier call summaries and profiling materials | |
| − | |||
| Line 20: | Line 19: | ||
'''''[[PDF BC Call Summaries Archive]]''''' | '''''[[PDF BC Call Summaries Archive]]''''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
==Reference Materials== | ==Reference Materials== | ||
| Line 46: | Line 24: | ||
*[[Media:QIBA Profile compliance clinical environment-30AUGUST2013.pdf|QIBA Profile Compliance - Clinical Environment]] ''30-August-2013'' | *[[Media:QIBA Profile compliance clinical environment-30AUGUST2013.pdf|QIBA Profile Compliance - Clinical Environment]] ''30-August-2013'' | ||
*[[Media:PDF MRI TC Update 20130130A.pdf|PDF-MRI Technical Committee Report to the Steering Committee - 01.31.2013]] | *[[Media:PDF MRI TC Update 20130130A.pdf|PDF-MRI Technical Committee Report to the Steering Committee - 01.31.2013]] | ||
| − | |||
*[[Media:MDACC QIBA Scans 20090215 Summary Plot.pdf|MDACC QIBA Scans 20090215 Summary Plot]] | *[[Media:MDACC QIBA Scans 20090215 Summary Plot.pdf|MDACC QIBA Scans 20090215 Summary Plot]] | ||
| Line 53: | Line 30: | ||
*[[Media:Siemens QIBA protocol 7-1-09 D PURDY.pdf|Siemens-QIBA Protocol -- July 1, 2009 -- Dr David Purdy]] | *[[Media:Siemens QIBA protocol 7-1-09 D PURDY.pdf|Siemens-QIBA Protocol -- July 1, 2009 -- Dr David Purdy]] | ||
*[[Media:UC_MDACC_Comparison_20090902Tcon.xls|MDACC/U Chicago Phantom Data Analysis Comparison -- Sept 2, 2009 -- Dr Edward Jackson]] | *[[Media:UC_MDACC_Comparison_20090902Tcon.xls|MDACC/U Chicago Phantom Data Analysis Comparison -- Sept 2, 2009 -- Dr Edward Jackson]] | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
Revision as of 16:43, 2 June 2019
- Co-chairs: Michael Boss, PhD; John Kirsch, PhD; Daniel Barboriak, MD
- RSNA Staff Support: Susan Stanfa
NOTICE: This committee has been dissolved as of June 6, 2018.
- PDF served as the launching point for work on DWI, DCE, and DSC, which now have their own Biomarker Committees, as well as DTI.
- This page is persisted to provide access to earlier call summaries and profiling materials
Recent PDF-MRI Meetings
Approved call summaries:
Reference Materials
- QIBA Profile Compliance - Clinical Environment 30-August-2013
- PDF-MRI Technical Committee Report to the Steering Committee - 01.31.2013
- Siemens-QIBA Protocol -- July 1, 2009 -- Dr David Purdy
- MDACC/U Chicago Phantom Data Analysis Comparison -- Sept 2, 2009 -- Dr Edward Jackson